Abstract:
Basically substituted 4-piperazino-benzene-1,3-disulfonamides, their non toxic salts and a process for their manufacture which process comprises introducing either the piperazino radical in 4position or the basic group in 6-position into corresponding 1,3benzene sulfonamides having an appropriate group in 4- or 6position in usual manner or by oxidizing compounds containing an allyl group which is interrupted by an S or an SO-group.
Abstract:
N-ACYLATED HALOBENZENE-2,4-DISULFONAMIDE OF THE FORMULA
1-X,2-(NH2-SO2-),4-(R1-CO-N(-R)-SO2-)BENZENE
IN WHICH X IS CHLORINE OR BROMINE; R IS METHYL, ETHYL OR TETRAHYDROFURFURYL; AND R1 IS ALKYL OF UP TO 8 CARBON ATOMS, CHLOROMETHYL, BROMOMETHYL, ALLYL, FURYL, CYCLOPENTYLMETHYL, PHENYL, BENZYL OR PHENYLETHYL, HAVE BEEN FOUND TO HAVE VALUABLE DIURETIC AND SALURETIC ACTIVITY.
Abstract:
What are disclosed are compounds of the formula I in which R denotes alkyl, alkenyl, cycloalkyl or cycloalkylalkyl, each of which has up to 10 C atoms, or phenyl and Ar denotes phenyl, thienyl or furyl and salts thereof, the preparation of these compounds and their use as medicaments and also medicaments of this type as such.
Abstract:
The invention relates to a 5-phenyltetrazole of the formula I (I) in which R denotes furyl or thienyl, to a physiologically acceptable salt thereof, to its preparation, to agents composed of or containing this compound and to its use as a drug.
Abstract:
What are disclosed are salidiuretic compounds of the formula and physiologically acceptable salts thereof, wherein R is phenyl, furyl or thienyl, intermediates of said compounds, methods for making said compounds, salidiuretic pharmaceutical preparations containing said compounds or salts, and methods for treating humans and other mammals with such compounds or salts.
Abstract:
Process for the preparation of sulfamoylantranilic acids of the general formula i ** (see formula) ** Wherein ph means a phenyl radical optionally substituted with 1-2 halogen atoms, alkyl groups or etherified hydroxy groups and r means aralcohyl, heteroaralkyl or cycloalkohilalcoyl radicals which in the aliphatic portion may be unsaturated, interrupted by oxygen or sulfur and/or in the aromatic portion they can be substituted with halogen atoms, alkyl or alkoxy radicals, characterized in that carboxylic acids of the general formula iv are reacted ** (see formula) ** At temperatures above 120º c, with at least one molar equivalent of an amine of the general formula r-nh2, wherein r has the above meanings. (Machine-translation by Google Translate, not legally binding)
Abstract:
Process for the preparation of sulfamoylantranilic acids of the general formula i ** (see formula) ** Wherein ph means a phenyl radical optionally substituted with 1-2 halogen atoms, alkyl groups or etherified hydroxy groups and r means aralcohyl, heteroaralkyl or cycloalkohilalcoyl radicals which in the aliphatic portion may be unsaturated, interrupted by oxygen or sulfur and/or in the aromatic portion they can be substituted with halogen atoms, alkyl or alkoxy radicals, characterized in that carboxylic acids of the general formula iv are reacted ** (see formula) ** At temperatures above 120º c, with at least one molar equivalent of an amine of the general formula r-nh2, wherein r has the above meanings. (Machine-translation by Google Translate, not legally binding)
Abstract:
Antihypertensively-active 3-sulfamoyl-4-piperazinyl-benzoic acids, optionally substituted in the 2-position by halogen or alkyl, and the esters, amides, and nitriles of these acids are disclosed, as is a method for making these compounds by the reaction of the corresponding 4-halogeno- or 4-alkyl-(or 4-aryl-) sulfonyloxy-benzoic acids (or their esters etc.) with piperazines.